Nebulized recombinant human p53 adenovirus
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nebulized recombinant human p53 adenovirus, covering 2025-09-02 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study [Phase 2]